Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overcoming doxorubicin resistance of cancer cells by Cas9-mediated gene disruption
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-10
DOI
10.1038/srep22847
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases
- (2015) Zhuchi Tu et al. Molecular Neurodegeneration
- Development and Applications of CRISPR-Cas9 for Genome Engineering
- (2014) Patrick D. Hsu et al. CELL
- Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA
- (2014) S. Ramakrishna et al. GENOME RESEARCH
- Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
- (2014) S. Kim et al. GENOME RESEARCH
- High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
- (2014) Yuexin Zhou et al. NATURE
- Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo
- (2014) John A Zuris et al. NATURE BIOTECHNOLOGY
- Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells
- (2013) Kyoung-Ran Kim et al. CHEMICAL COMMUNICATIONS
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs
- (2013) Kristopher Montrose et al. Scientific Reports
- Engineered Nanocarriers of Doxorubicin: A Current Update
- (2012) Rajesh R. Patil et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Computational models for predicting substrates or inhibitors of P-glycoprotein
- (2011) Lei Chen et al. DRUG DISCOVERY TODAY
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group
- (2011) Natalya S. Petrova et al. NUCLEIC ACIDS RESEARCH
- DNA Self-assembly for Nanomedicine
- (2010) Rahul Chhabra et al. ADVANCED DRUG DELIVERY REVIEWS
- Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells
- (2010) Meysam Abbasi et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now